Bruun Stine Bakkensen, Madsen Jeppe Buur, Brasen Claus Lohman
Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100 Vejle, Denmark.
Department of Regional Health Research, University of Southern Denmark, J. B. Winsløwsvej 19, 5000 Odense, Denmark.
Diagnostics (Basel). 2023 Jun 2;13(11):1951. doi: 10.3390/diagnostics13111951.
Krebs von den Lungen-6 (KL-6) is a promising biomarker for the diagnosis and prognosis of interstitial lung disease. However, reference intervals in Northern Europeans remain to be established using a latex-particle-enhanced turbidimetric immunoassay. The participants were Danish blood donors subjected to strict health requirements. Analyses were performed using the Nanopia KL-6 reagent on the cobas 8000 module c502. Sex-partitioned reference intervals were determined using a parametric quantile approach according to the Clinical and Laboratory Standards Institute guideline EP28-A3c. The study included 240 participants-121 females and 119 males. The common reference interval was 59.4-398.5 U/mL (95% confidence intervals (CI) for the lower and upper limits were 47.3-71.9 and 369.5-430.1, respectively). For females, the reference interval was 56.8-324.0 U/mL (95% CIs for the lower and upper limits were 36.1-77.6 and 303.3-344.7, respectively). For males, the reference interval was 51.5-448.7 U/mL (95% CIs for the lower and upper limits were 32.8-71.2 and 397.3-508.1, respectively). These results emphasize the importance of sex partitioning when evaluating KL-6 reference intervals. The reference intervals increase the clinical applicability of the KL-6 biomarker and provide a basis for future scientific studies of its utility in patient management.
肺 Krebs von den Lungen-6(KL-6)是间质性肺疾病诊断和预后的一种有前景的生物标志物。然而,北欧人群中使用乳胶颗粒增强比浊免疫测定法的参考区间仍有待确定。参与者为符合严格健康要求的丹麦献血者。使用 cobas 8000 模块 c502 上的 Nanopia KL-6 试剂进行分析。根据临床和实验室标准协会指南 EP28-A3c,采用参数分位数方法确定按性别划分的参考区间。该研究纳入了 240 名参与者,其中 121 名女性和 119 名男性。通用参考区间为 59.4 - 398.5 U/mL(下限和上限的 95%置信区间分别为 47.3 - 71.9 和 369.5 - 430.1)。女性的参考区间为 56.8 - 324.0 U/mL(下限和上限的 95%置信区间分别为 36.1 - 77.6 和 303.3 - 344.7)。男性的参考区间为 51.5 - 448.7 U/mL(下限和上限的 95%置信区间分别为 32.8 - 71.2 和 397.3 - 508.1)。这些结果强调了在评估 KL-6 参考区间时按性别划分的重要性。参考区间提高了 KL-6 生物标志物的临床适用性,并为其在患者管理中的效用的未来科学研究提供了基础。